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1. ABSTRACT 
Macrophages are essential in the inflammatory response and also have 
a critical function in body iron homeostasis. Moreover, it is known that 
iron metabolism is important in the context of inflammation. Indeed, it 
has been demonstrated that, in line with their functions, distinct 
macrophage populations, such as M1 and M2 polarized cells, differ in 
the expression of genes involved in iron homeostasis as well as in the 
expression of immunoregulatory genes. The functional significance of 
these differencies are not completely understood: we hypotized that iron 
released by M2 macrophages could promote cell proliferation and 
extracellular matrix deposition in the resolution phase of inflammation. 
Moreover, in line with the increasing awareness that macrophages have 
an important trophic role in addition to their immunological function, 
macrophages may play a role of “local iron redistributors” in tissues, 
where they would manage iron availability for neighbouring cells. 
Therefore, the major aim of this project was to exploit a mouse model of 
impaired iron release from macrophages, caused by deletion of 
Ferroportin (Fpn), to understand the functions of macrophage iron in two 
situations of tissue repair: cutaneous wound healing and liver fibrosis. 
The characterization of mice with loss of macrophage Fpn showed that 
they are affected by transient alopecia caused by impaired hair follicle 
growth. The local impairment of iron distribution due to macrophage Fpn 
inactivation was accompanied by cellular iron deprivation and 
decreased proliferation in adjacent epithelial cells. By exposing mice to 
an iron-restricted diet we concluded that hair loss was not related to 
hypoferremia/anemia. Taken together, these results suggest that iron 
retention in resident macrophages has detrimental effects on tissue 
homeostasis by inhibiting the proliferation of hair follicle cells. 
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We observed a considerable delay in the closure of excisional skin 
wounds of Fpnfl/flLysCre/- mice compared to controls, with defective 
granulation tissue formation and diminished fibroplasia. Moreover, the 
development of both lymphatic and blood vascular network was 
impaired. Conversely, inactivation of Fpn in macrophages had no 
impact on inflammatory processes accompanying wound healing, such 
as production of inflammatory molecules, content of leukocyte subsets 
and macrophage polarization. Altogether, these results indicate that, 
though it does not interfere with immune cells recruitment and local 
activation, Fpn deletion in macrophages impairs blood vessels formation 
and stromal cells proliferation, leading to delayed skin repair. 
Fpn inactivation in macrophages had no impact on inflammation, 
steatosis and fibrosis associated with exposition to the MCD diet, a model 
of non-alcoholic steatohepatitis. Levels of inflammatory and fibrogenic 
markers did not show significant differences between Fpnfl/flLysCre/- mice 
and controls. Interestingly, the levels of transaminases were significantly 
lower in mice with Fpn inactivation in macrophages, suggesting a 
different susceptibility to liver damage. These data suggest that, in this 
model, Fpn deletion in macrophages does not affect the inflammatory 
response to liver damage and fibrogenesis. The different susceptibility to 
liver damage and the different results we observed in the cutaneous 
wound healing and in the process of hepatic fibrosis should be further 
explored, perhaps using another model of fibrosis. 
In conclusion, the results reported in this thesis indicate that the 
macrophage trophic function in skin homeostasis and healing is iron and 
Fpn-dependent.   
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2. INTRODUCTION 
2.1 The importance of iron homeostasis 
Iron is a key element for many physiological processes in most organisms, 
from bacteria to mammals: it is incorporated in proteins performing key 
functions, such as oxygen transport and storage (eg hemoglobin and 
myoglobin), electron transfer (eg cytochromes) and DNA synthesis 4. 
However, an excess of "free" iron is dangerous since it could lead to the 
formation of Reactive Oxygen Species (ROS), capable of damaging 
biological molecules and hence leading to cell death and tissue injury 5. 
Disorders in iron homeostasis can lead to either iron deficiency or iron 
overload and contribute to several medical conditions, such as anemia 
and hemochromatosis.  
Control of iron levels is also fundamental for the outcome of the 
competition over iron between the host and the invading pathogens6. 
Since iron is a fundamental growth factor for most parasites and 
bacteria, these microorganisms have developed several mechanisms for 
acquiring iron in low-iron environments. These processes include: the 
secretion of molecules that bind free iron with very high affinity 
(siderophores), the absorption of heme released from red blood cells 
after hemolysis and the ability to obtain iron from host iron-binding 
proteins (such as hemoglobin, transferrin and lactoferrin) 6,7. Conversely, 
given the important role of iron for pathogen virulence, it is not surprising 
that the host has developed various mechanisms to control iron 
availability.  
Therefore, iron homeostasis is strictly regulated and appropriate iron 
levels are maintained thanks to a complex network of proteins that co-
ordinately regulate absorption, storage, recycling and use of iron both at 
systemic and cellular levels 8. 
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Figure 1. Iron absorption by duodenal 
enterocytes. 
In duodenum iron is absorbed from diet via 
DMT1. Then is stored by Ft, used or 
released in the circulation via Fpn. In the 
bloodstream, iron is bound to serum 
protein Tf. 
2.1.1 Systemic iron metabolism 
On average, an adult human body contains 3–5 g of iron (50 mg/kg). 
Approximately 60% (2500 mg) of the total body iron content is found in 
circulating hemoglobin, and most of the rest is represented by storage 
iron distributed throughout various body tissues. Only about 20 % of the 
daily iron requirement comes from diet; almost 80% comes from the 
recovery of the metal from senescent red blood cells by macrophages 
of the reticuloendothelial system in the spleen red pulp and liver (Kupffer 
cells). These specialized phagocytes, 
which differentiate and develop via 
a process dependent on the SPI-C 
transcription factor 9, process old 
and/or defective erythrocytes and 
return hemoglobin-derived iron to 
the circulation for a new utilization 10. 
Iron absorption takes place in the 
proximal small intestine, near the 
gastro-duodenal junction; here, non-
heme iron is absorbed principally 
through the activity of the Divalent 
Metal Transporter 1 (DMT1), which 
transports the metal, in its ferrous 
form (Fe2+), from the intestinal lumen 
into the cytosol of the enterocytes 
(Figure 1); absorption of heme iron is 
quantitatively more important but less 
characterized at the molecular level. 
Once internalized in the duodenal 
8 
 
Figure 2.HAMP interaction with Fpn controls iron flux 
through plasma. 
HAMP negatively modulates iron absorption from the 
diet, recycling from reticuloendothelial cells and release 
from liver storages 2 
cell, iron can be stored by the iron storage protein ferritin (Ft) 11 or 
exported into plasma by ferroportin 1(Fpn), the only known mammalian 
non-heme iron exporter 12.In the blood stream, iron is bound and safely 
carried to the various tissues by serum Tf (Figure 1). The Tf saturation by 
iron varies on a diurnal cycle and rapidly responds to local stimuli: it is 
higher in the portal circulation and lower in plasma leaving the erythroid 
bone marrow, where most of the iron is used by erythroid precursors cells. 
Under physiological conditions, Tf is partially saturated (around 30%) and 
can bind excess iron entering the circulation, thus protecting against iron 
toxicity. 
The liver derived peptide hepcidin (HAMP) is the main regulator of 
systemic iron metabolism: it binds Fpn and induces its internalization and 
degradation 13. By so doing, it plays a fundamental role in modulating 
the release of iron from 
duodenal enterocytes, 
spleen macrophages and 
hepatocytes, negatively 
modulating iron absorption 
from the diet, recycling 
from macrophages and 
also release from the liver 
13,as hepatocytes serve as 
major depot for iron 
storage (Figure 2). At the 
systemic level, this 
mechanism results in a 
decrease in both plasma 
iron concentration and Tf 
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saturation. HAMP expression is regulated by a variety of different signals; 
in particular, it is induced by iron stores and inflammatory stimuli 14. In 
fact, HAMP is an acute-phase protein 15 and represents the mayor 
response of host iron metabolism upon microbial invasion and 
inflammation. It has been shown that interleukin 6 (IL-6), one of the most 
important pro-inflammatory cytokines involved in the acute phase 
response, promotes HAMP expression 16 thus blocking Fpn-dependent 
iron release and leading to hypoferremia and low Tf saturation. Of 
course, this restricted iron availability affects also erythroid progenitor 
cells, and prolonged hypoferremia may limit hemoglobin synthesis and 
cause the so-called anemia of chronic disease (ACD) 4,17. 
2.1.2 Cellular iron metabolism 
Cells that require iron express Transferrin Receptor 1 (TfR1) at the cell 
surface and, upon binding, the complex of TfR1 and iron-loaded Tf is 
internalized through a process of clathrin-mediated endocytosis 18 
(Figure 3). Inside the cell, the endosome containing the internalized 
Figure 3. Iron entrance in the cell. 
Tf interaction with Tfr1 causes the endocytosis of the protein complex and the release of 
iron in the cytosol. Iron can then be stored in Ft or used for the needs of the cell. 
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complex is acidified to a pH of about 5.5 by a vacuolar H+-ATPase (V-
ATPase). This acidification process produces conformational changes in 
the Tf-TfR1 complex with consequent release of iron, which is then 
transported to the cytosol by DMT1. At acidic pH, apo-transferrin (iron-
free Tf) remains bound to TfR1 and the complex is recycled back to the 
cell surface. At the pH of the plasma, apo-transferrin dissociates from 
TfR1 and the receptor is ready for a new cycle of iron uptake 19. Inside 
the cell, iron can be utilized for the metabolic needs of the cell itself, 
released through Fpn or stored for future necessities. In the last case, to 
avoid the intrinsic redox activity of the metal, the iron ions are 
sequestered by Ft, an heteropolymeric protein composed of 24 subunits 
assembled to form a spherical structure with an inner cavity in which iron 
is stored safely 20. Therefore, Ft represents both a storage protein and an 
antioxidant factor. Fpn is a transmembrane protein that acts as an iron 
exporter, exporting iron out of cells. Fpn transports iron in its ferrous form, 
but an efficient iron export requires the activity of the oxidases 
ceruloplasmin (circulating) and hephaestin (membrane-bound, mainly 
expressed in the duodenum), which oxidize the metal to its ferric form 
that is accepted by Tf. Fpn structure has not yet been elucidated 
because there are no close structurally characterized homologs. The 
best-supported Fpn model has 12 transmembrane segments with both 
termini located intracellularly 21. The crystal structure of a putative 
bacterial homolog of Fpn suggests that the protein is made of two lobes 
separated by a cytosolic loop 22. The central cavity between the two 
lobes contains the iron-binding site and it can be either facing the 
cytosol or open to the extracellular space, depending on the spatial 
disposition of the two lobes. Transition between these two conformations 
could explain the iron export activity of Fpn. 
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The modulation of Fpn expression is complex and involves transcriptional, 
translational and post-translational mechanisms. The promoter of the Fpn 
gene contains hypoxia-response elements (HREs), targets of hypoxia 
Inducible Factors (HIFs), as shown by the HIF2alpha-dependent increase 
in Fpn transcription during hypoxia and iron deficiency 23. On the 
contrary, inflammation decreases transcription of Fpn, though this 
mechanism is only partially characterized. LPS causes a downregulation 
of duodenal Fpn 24 and the Mycoplasma-derived molecule FSL1 reduces 
splenic and liver levels of Fpn mRNA 25. At the translational level, iron itself 
modulates Fpn expression: in fact, Fpn mRNA contains a 5’ iron response 
element (IRE), which under conditions of iron deficiency is bound by iron 
regulatory proteins (IRPs), thus resulting in translational repression 26. 
Conversely, when iron is abundant IRPs binding activity is inhibited, 
thereby leading to active Fpn mRNA translation. IRPs are the major 
regulators of intracellular iron homeostasis, as they control also the 
translation of Ft and the stability of TfR1 mRNA. In addition, the activity of 
the transporter is predominantly governed post-translationally by HAMP: 
its binding to Fpn results in endocytosis and proteolysis of the exporter, 
predominantly in lysosomes 13. Although the structural details of the 
HAMP-Fpn interaction are not fully understood, we now know that Fpn, 
as other receptors that undergo ligand-induced endocytosis, goes 
through a conformational change, followed by covalent modifications 
of its cytoplasmic segment. In addition, the interaction with HAMP causes 
ubiquitination of multiple lysine residues in the cytoplasmic loop 
connecting the two lobes of Fpn 27. The details of this mechanism remain 
to be elucidated. 
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2.2 Macrophage iron metabolism 
Resident macrophages are constitutively present in organs, in the 
absence of inflammation, and perform trophic and homeostatic 
functions: they remove apoptotic cells and serve as sentinels of injury 
and infection. Macrophages also play a critical role in body iron 
homeostasis: splenic reticuloendothelial macrophages recover iron from 
senescent erythrocytes and release it back to circulation. Macrophages 
play an essential role in the inflammatory response. In the site of 
inflammation are present recruited macrophages originated from 
peripheral blood monocytes, as well as resident macrophages, and both 
populations reveal a great heterogeneity of phenotypes and 
specialization: macrophages can acquire cytotoxic and antimicrobial 
activities i.e. classic pro-inflammatory (M1) macrophages, but also 
initiate repair and resolve inflammation, defined as alternative polarized 
(M2) macrophages 28.It is known that iron metabolism is important in the 
context of inflammation and in line with their different functions in 
homeostatic and inflammatory conditions, different macrophage 
populations differ in the expression of genes involved in iron homeostasis 
29,30 as well as in the expression of immunoregulatory genes 31. In 
particular, pro-inflammatory M1 macrophages show lower expression of 
Fpn and the consequent iron retention correlates with high expression 
levels of Ft 29 (Figure 4). On the contrary, alternative polarized M2 
macrophages, involved in debris scavenging, angiogenesis and 
connective tissue remodelling, show higher expression of Fpn compared 
to M1 cells 29 (Figure 4): this sustains the propensity of M2 macrophages 
to actively export iron into the microenvironment 30,32. These cells also 
show an increased expression of heme oxygenase (HO-1), which 
catalyzes the oxidative degradation of heme, endowed with pro-oxidant 
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and pro-inflammatory activity. Heme catabolism produces iron, 
biliverdin, subsequently converted into bilirubin, possessing anti-
inflammatory and anti-oxidant properties, and CO, which promotes 
vasodilatation and angiogenesis 30. 
Moreover, a study 33 showed that M2 macrophages are characterized 
by improved expression of the Hb scavenger receptor CD163, increased 
heme uptake, heme-degradation and export of heme-derived iron. The 
greater availability of heme and non-heme iron in M2 macrophages 
cooperates with the high Fpn expression to increase ferrous iron export 
into the surrounding microenvironment (Figure 4). 
The functional significance of these activities are not completely 
understood, it is reasonable to assume that iron released by M2 
Figure 4.Macrophage polarization affects the expression of genes of iron homeostasis. 
M1 macrophages are characterized by high Ft and low Fpn expression which sustains their 
inclination to store iron and deplete the microenvironment. On the contrary, M2 macrophages are 
characterized by low Ft and high Fpn, scavenger receptors and HO-1, which mediate efficient iron 
uptake and recirculation. 
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macrophages could be available for adjacent cells, such as fibroblasts, 
and promote proliferation and extracellular matrix (ECM) deposition. The 
latter function is in line with the iron-dependency of the prolyl 
hydroxylases required for collagen biosynthesis 34,35. Moreover, heme 
scavenging could be a relevant mechanism to prevent the pro-oxidant 
and proinflammatory activities of this molecule, derived from the 
hemolysis that accompanies inflammation 36, while producing CO, with 
its anti-inflammatory and angiogenetic properties. Since inflammation is 
a dynamic process, it is also plausible that in the late phases of 
inflammation M2 macrophages release the iron previously accumulated 
under proinflammatory conditions, thus contributing to inflammation 
resolution. 
2.3 Macrophages in skin homeostasis and tissue repair 
In the skin, resident macrophages play an important role both in tissue 
homeostasis and in repair from injury 37-39. Under physiological conditions, 
macrophages support parenchymal cells with trophic signals and 
nutrients and are critical regulators of hair follicle growth 40: perifollicular 
macrophages stimulate hair follicle stem cells to enter in the growth 
phase (anagen) 41. In pathological conditions, selective ablation of 
macrophages impairs various phases in the wound healing process 42. 
Cutaneous wound healing is a dynamic process involving the 
differentiation, migration, proliferation, and apoptosis of various cell 
types, and is a very useful model to study macrophage differentiation 
and heterogeneity. Normal cutaneous wound repair is characterized by 
three major stages: the inflammatory, proliferative, and remodelling 
phases 3. 
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During the inflammatory phase, haemostasis represents the immediate 
response to injury and prevents blood loss at the wound site. Vascular 
injury causes a local activation of the innate immune system, resulting in 
an influx of inflammatory cells (Figure 5) attracted to the site of injury by 
cytokines, including transforming growth factor β (TGF-β) and platelet-
derived growth factor (PDGF) 43,44. Infiltrating neutrophils remove foreign 
corps from the wound area and are then extruded with the eschar or 
phagocytized by macrophages. In response to specific chemokines, 
monocytes infiltrate the wound area too and differentiate into 
macrophages 45. In this phase, the recruited and resident macrophage 
populations proliferate and undergo a classic pro-inflammatory M1 
polarization, characterized by the production of oxygen radicals and 
pro-inflammatory cytokines and phagocytosis of foreign organisms. They 
also release TGF-β, PDGF and vascular endothelial growth factor (VEGF), 
thus stimulating the movement of fibroblasts and epithelial cells into the 
wound 37,38. The inflammatory response is an essential component of the 
wound healing process: it is decisive to protect the body from foreign 
microorganisms and many of the cytokines and growth factors released 
during this process support the ensuing tissue repair. However, an 
 
 
Figure 5. Stages of wound repair: 
inflammation. 
Platelets facilitate haemostasis and 
secrete several mediators that attract 
and activate neutrophils and monocities 
(modified from 
3
). 
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excessive inflammatory response or the presence of a chronic insult may 
lead to fibrosis and scar formation. 
The proliferative phase is characterized by re-epithelialization of the 
epidermis, repair of the dermal layer and neo angiogenesis (Figure 6). 
The dermal wound space is refilled by invading and proliferating 
fibroblasts that separate the eschar from viable tissue. These fibroblasts 
synthesize and secrete extracellular matrix (ECM) that facilitates cell 
adhesion, migration and proliferation of other cells46and also release 
growth factors, such as TGF-β 47. New stroma, also called granulation 
tissue, begins to occupy the wound area: macrophages and fibroblasts 
infiltrate the lesion space and new blood vessels form 43. In this phase the 
macrophage populations show a M1 to M2 switch and alternative 
polarized macrophages, oriented to tissue repair and remodelling, 
predominate 37,48. Macrophages represent a continuous source of 
growth factors (such as VEGF), so the M1 to M2 switch is essential for the 
healing process 38. 
During the remodelling (or maturation) phase all the processes activated 
after injury come to an end : most of the endothelial cells, macrophages 
and fibroblasts undergo apoptosis or leave the wound site (Figure 7). 
Wound fibroblasts at this stage tend to adopt a contractile myofibroblast 
 
 
Figure 6. Stages of wound repair: 
proliferation. 
Under the eschar, macrophages and 
fibroblasts invade the wound 
stimulating the formation of new blood 
vessels. All these events form the 
granulation tissue, the precursor of new 
stroma (modified from 
3
). 
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phenotype 49,50 characterized by large bunches of actin microfilaments 
and cell-matrix and cell-cell linkages. 
The maturation of the wound site, following deposition of ECM, changes 
the properties of the tissue: this involves the degradation and 
replacement of collagen type III with collagen I 3,44. Collagen 
remodelling during the transition from granulation tissue to scar is 
mediated by several proteolytic enzymes called matrix 
metalloproteinases, secreted by macrophages, endothelial cells and 
fibroblasts. Together, these transformations result in the contraction of the 
wound and the arrangement of new tissue. 
A tight control of iron metabolism is needed for appropriate skin wound 
healing. Previous evidence showed that excess iron, both in 
macrophages and in the extracellular environment, has a negative 
effect on tissue repair 51. However, it is also plausible that iron retention in 
macrophages leads to lower iron availability for neighbouring cells, thus 
compromising the trophic role of macrophages, in the proliferative 
phase. This reduced iron availability could negatively influence the 
growth rate of various cell types (fibroblasts, epithelial and endothelial 
cells) and consequently the new tissue formation. To this regard, it is 
 
 
Figure 7. Stages of wound repair: 
maturation. 
The shift of fibroblast to myofibroblast 
phenotype and the replacement of collagen 
type III with type I result in the contraction of 
the wound and new tissue formation 
(modified from 
3
). 
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important to remember the fundamental role of iron in collagen 
biosynthesis 52. 
2.4 Macrophages in liver fibrosis 
Liver fibrosis is an aberrant wound-healing process, characterized by the 
accumulation of ECM in the hepatic parenchyma, caused by increased 
production (fibrogenesis) or by inadequate degradation (fibrolysis) of 
ECM. Fibrosis represents the common end point of various hepatic insults, 
such as viral hepatitis, alcoholic and non-alcoholic fatty liver disease 
(NAFLD) 1. In particular, NAFLD is the most prevalent liver disease in 
Western clinical practice and frequently evolves in non-alcoholic 
steatohepatitis (NASH), liver fibrosis, and hepatocellular carcinoma 53. 
Physiologically, upon liver damage, inflammatory cells are activated: 
these include cells of the monocyte/macrophage lineage, both resident 
(Kupffer cells) and infiltrating 54-56. The resulting inflammatory cascade 
leads to activation and proliferation of hepatic stellate cells (HSCs), a 
population of fibroblast-like cells resident in the space of Disse, which are 
primarily involved in extracellular matrix deposition (Figure 9): activated 
HSCs secrete collagen and express tissue inhibitors of metalloproteinases 
(TIMPs), thus resulting in matrix-degrading metalloproteinase activity 
inhibition. The consequent increased production of ECM, and its 
deposition in the space of Disse, cause alterations in liver architecture 
(such as the loss of endothelial fenestration and hepatocytes microvilli) 
and an impairment of normal metabolic exchange between portal 
venous flow and hepatocytes. These changes are normally transient and 
the regular structure is quickly restored, but, if the injury persists and 
becomes chronic, inflammation and accumulation of ECM continue 
and soon fibrogenesis exceed fibrolysis. This leads to the real process of 
fibrosis: a progressive substitution of liver parenchyma with scar tissue. The 
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end consequence of continuous fibrosis is cirrhosis, the irreversible and 
complete loss of tissue architecture and function that represents a major 
cause of morbidity and mortality worldwide 1.  The main hypothesis of 
NAFLD progression to liver fibrosis is considered to be the augmented 
susceptibility to oxidative stress and inflammatory cytokines in fatty liver 
57. However, the molecular events and mechanisms responsible for this 
progression remain to be fully clarified. Experimental animal models can 
provide a great opportunity to bypass the environmental factors and 
genetic heterogeneity influencing NAFLD in humans. There are several 
diet-induced models of NAFLD in rodents; the methionine-choline 
deficient (MCD) diet is the most widely used in mice. It rapidly induces a 
pathological condition progressing from macrovesicular steatosis to 
hepatic fibrosis, depending on duration of the administration 58. 
 
Figure 9. Matrix and cellular alteration in liver fibrosis. 
Deposition of ECM in the space of Disse leads to the loss of endothelial fenestrations and hepatocyte microvilli, 
which results in the impairment of normal bidirectional metabolic exchange between portal venous flow and 
hepatocytes (Modified from 
1
). 
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The role of both recruited monocytes and Kupffer cells in the process of 
liver fibrosis is crucial but controversial: they not only participate in the 
initial inflammatory response and induction of fibrogenesis, but seems 
also involved in fibrosis resolution 54-56.This ability of macrophages to act in 
both a pro- and anti-fibrotic manner has been partially explained by 
studies suggesting that these various functions may be performed by 
distinct macrophage populations (Figure 10). M1 macrophages appear 
to be pro-fibrotic 59,thanks to their production of oxygen radicals and 
pro-inflammatory cytokines. Conversely, M2 macrophages have a more 
controversial 54,60 role, depending on the specific subpopulation in which 
they differentiate. M2a-like macrophages, which produce cytokines that 
activate myofibroblasts (such as TGF-β), seem to support the progression 
Figure 10. Different macrophage subpopulations have different roles in fibrosis. 
M1 macrophages have a pro-fibrotic effect; M2a-like macrophages seem to support the progression of 
fibrotic disease, whereas differentiation into M2c-like macrophages, appears to promote fibrosis resolution. 
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of fibrotic disease; on the contrary, differentiation into M2c-like (or Mreg) 
macrophages promotes fibrosis resolution 56, by inhibiting M1, M2a-like 
and myofibroblasts activity through IL-10 and arginase1 production. The 
balance between different macrophage subsets, which depends on the 
microenvironment signals, seems to determine whether the outcome is 
resolution and healing or fibrosis. 
2.4.1 Iron and fibrosis 
Another possible explanation of the plasticity of macrophages in liver 
fibrosis could be the role of iron release or retention by macrophages. 
Numerous studies indicate that excessive iron stores worsen liver fibrosis 
61; Specifically, increased hepatic iron content is associated with the 
progression of liver disease in patients with hereditary hemochromatosis 
62. In this condition, the pathologic iron accumulation causes a process 
of lipid peroxidation in hepatocytes, leading to hepatocellular necrosis 
and aggravating the fibrotic state. In line with this concept, iron-removal 
therapies are effective lifesaving strategies. However, evidence that iron 
is a potent co-factor in the pathogenesis of fibrosis both in humans and 
animal models has been obtained mainly under conditions of increased 
total liver iron content and systemic iron overload 61. Consequently, a 
harmful role of increased iron levels in selected cells has been proposed: 
redox active iron in hepatocytes, by catalyzing the formation of noxious 
ROS, may increase oxidative damage and affect signaling pathways 
involved in cell death and inflammation 63. Moreover, it has been shown 
that iron overloaded Kupffer cells, in the presence of hepatocellular 
damage, are overactivated, greatly increase ROS production and may 
constitute a major drive to fibrosis 64. In NAFLD, mild hepatic iron 
accumulation is seen in up to 30% of patients 65 and iron has been 
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implicated in cellular oxidative stress and insulin resistance, key features 
of NAFLD pathogenesis, and advanced fibrosis 66. 
Still, it cannot be dismissed that liver fibrosis can be favoured also by an 
increased iron release by M2 macrophages. Indeed, the availability of 
iron in the extracellular environment is necessary for tissue growth and 
could influence the proliferation of adjacent fibroblasts and facilitate 
extracellular matrix deposition, in particular collagen synthesis 52. 
Therefore, the role of macrophage-derived iron trafficking and 
compartmentalization in the process of liver fibrosis should be better 
clarified. 
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3. AIMS 
Macrophages are essential in the inflammatory response. It is also known 
that iron metabolism is important in the context of inflammation and, in 
line with their different functions in homeostatic and inflammatory 
conditions, different macrophage populations differ in the expression of 
genes involved in iron homeostasis 29,30 as well as in the expression of 
immunoregulatory genes 31. Understanding pathogenetic processes 
activated by altered macrophage iron trafficking could contribute to 
better understanding of how iron plays a major role in inflammation, and 
will hopefully help the development of novel therapeutic strategies. 
Therefore, the aim of this project was to better understand the role of 
macrophage iron handling in inflammatory responses. 
In particular, the study exploited a mouse model of impaired iron release 
from macrophages caused by cell-specific deletion of Fpn in order to try 
to: 
1. Clarify the role of macrophage iron in cutaneous wound healing, a 
process characterized by a complex inflammatory response 
involving the presence, at different stages, of various macrophage 
polarized populations. 
2. Investigate the role of macrophage iron in the context of liver 
fibrosis, a process with several analogies with cutaneous wound 
healing and in which iron seems to play an important role, using an 
experimental model recapitulating NAFLD, a diffuse pathology that 
may lead to fibrosis. 
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4. METHODS 
4.1 Animals and dietary intervention 
Mice carrying the floxed Fpn allele (Fpnfl/fl) 12, kindly provided by Dr 
Nancy Andrews (Duke University), were bred to mice expressing Cre 
recombinase under the control of the macrophage-specific promoter 
Lysozyme M (LysM) in the C57BL/6J background (backcrossed for 10 
generations) in order to generate mice with specific Fpn inactivation in 
monocyte–macrophage cell lineage (Fpnfl/flLysCre/-)(Figure 11). 
Fpnfl/flLysCre/- mice were 
cohoused with littermates 
Fpnfl/flLys-/- mice in 
individually ventilated 
cages in a specific 
pathogen–free animal 
facility at Humanitas 
Clinical and Research 
Center. Mice were typically 
maintained with normal 
diet (157 ppm iron content) 
and pups were weaned at 
3 weeks of age. For the 
iron-deficiency, dams and 
pups were fed with an iron-
deficient diet (9 ppm iron content; ssniff® EF R/M iron-deficient 
experimental diet, Charles River) from birth to 5 weeks after birth. Only 
some groups were given an iron-deficient diet for 11 weeks after birth, as 
indicated. Alopecia was quantified as follows: 100% = complete hair loss 
on the trunk; 50% = initial thin dorsal pelage; 0% = normal coat hair. 
Figure 11. Genesis of a mouse model with a specific 
inactivation of Fpn in monocyte–macrophage cell lineage. 
Mice carrying a floxed Fpn allele were bred to mice expressing 
Cre under the control of the macrophage-specific promoter 
LysM in the C57BL/6 background. 
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Procedures involving animals handling and care were conformed to 
protocols approved by the Humanitas Clinical and Research Center in 
compliance with national (DL 116, GU suppl. 40, 18-2-1992; DL 26, GU 4-3-
2014) and international law and policies (EEC Council Directive 
2010/63/EU, OJ L 276/33, 22–09-2010; National Institutes of Health Guide 
for the Care and Use of Laboratory Animals, US National Research 
Council, 2011). The study was approved by the Italian Ministry of Health. 
All efforts were made to minimize the number of animals used and their 
suffering. 
Genotyping was performed by PCR using the GoTaq Green Master Mix 
(Promega, Madison, WI) according to the manufacturer’s protocol. Both 
the wild-type (350 bp) and the mutant alleles (700 bp) were identified by 
amplification with the same forward primer and a specific reverse primer 
(Table 1). 
Table 1. Genotyping Primers 
Primer Type Sequence 
Common forward primer CTT GGG CTG CCA GAA TTT CTC 
Wild-type reverse primer TTA CAG TCG GCC AGG CTG AC 
Mutant reverse primer CCC AGA AAT GCC AGA TTA CG 
 
4.2 Blood analyses 
Blood was collected by cardiac puncture and Hb and Hct levels were 
immediately measured using a photometric analyser (HemoControl, EKF 
diagnostic, UK). Blood samples were centrifuged at 1500 g for 10 min at 
4°C, and serum was stored at −20°C until analysis. Serum iron was 
measured using an UIBC/Iron kit (Thermo Scientific) and serum ALT and 
AST activity was determined using Reflotron® Plus system (Roche 
Diagnostics, Switzerland). 
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4.3 Skin wound healing model 
To generate a punch wound, the back of anesthetized mice was shaved 
and exposed skin was cleaned with 70% ethanol. A full-thickness wound 
was created with a disposable 8-mm-diam biopsy punch by excising the 
skin and the underlying panniculus carnosus 67. Gentamicin was 
immediately applied and upon histological analysis no gross infection 
was apparent through day 14. Wound sites of each mouse were digitally 
photographed and measured every day in the course of wound healing. 
The edges of the wounds were daily traced onto a transparency and the 
areas of open wounds were calculated using ImageJ software (v1.45q, 
NIH, USA). Changes of wound area over time were expressed as 
percentage of the initial wound areas. The animals were sacrificed at 
different times and skin biopsies were fixed with 4% paraformaldehyde, 
and embedded in paraffin or dehydrated with a sucrose gradient and 
embedded in OCT compound (Diapath, Bergamo, Italy) and stored at -
80°C for histology or confocal microscopy analysis, respectively. 
Alternatively, skin biopsies were directly used for FACS and ELISA. 
4.4 MCD diet model 
Male 10-week-old C57BL/6 mice were randomly allocated into 2 groups. 
Mice in the MCD group (n=24) were fed on the MCD diet (Laboratori 
Dottori Piccioni) for 8 weeks. Control group (n=12) was fed on a 
methionine-choline-sufficient control diet, supplemented with choline 
chloride (2 g/kg diet) and D,Lmethionine (3 g/kg diet). Animals were 
sacrificed at 18 weeks. Livers were dissected out, examined for 
macroscopic lesions, frozen and kept at − 80 ◦C for RNA and protein 
extraction. A portion of the liver was immediately fixed with 4% 
paraformaldehyde and embedded in paraffin for histological analysis. 
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Blood was collected by cardiac puncture, centrifuged and serum stored 
for transaminases analysis. 
4.5 Primary cell cultures 
Bone marrow derived macrophages (BMDM) were generated as 
previously reported 68. Briefly, bone marrow aspirates from femur of 8 to 
12 week old mice were harvested and flushed out with Iscove modified 
Dulbecco medium (IMDM), 10% fetal calf serum (FCS) (Euroclone, Pero, 
Italy). After addition of ACK lysis buffer (Thermo Scientific, Milano, Italy) 
for red cells lysis, bone marrow cells where left to adhere overnight. Non-
adherent cells were centrifuged and suspended at 0.5 x 106 cells/mL in 
complete bone marrow macrophage medium (IMDM, 10% FCS, 150 μM 
MTG, 10 ng/mL M-CSF) and cultured for 7 days. BMDM were stimulated 
by changing the medium to IMDM, 10% FCS, 150 μM MTG, 1% P/S, 1% L-
glutamine, and 100 ng/mL LPS plus 20 ng/mL IFNγ or 20 ng/mL IL-4 for 24 
h. Peritoneal exudate cells (PEC) were recovered from the peritoneal 
cavity of mice injected with 1 ml of 3% (wt/vol) dithioglycolate (Difco, BD 
Biosciences, Milano, Italy) as previously reported 69. Briefly, 4-5 days after 
treatment, peritoneal cells were recovered in 5 ml of saline, centrifuged 
at 400 x g for 8 minutes, and cultured for 1 h in RPMI medium. After 
washing with  phosphate buffered saline (PBS), adherent macrophages 
were cultured in RPMI containing 10% FCS. 
4.6 Histopathological analysis 
Organs and tissues were examined for gross lesions, trimmed after 
complete fixation and processed for paraffin blocks embedding. For 
histopathological analysis, 4 μm thick tissue sections obtained from the 
paraffin blocks were stained with hematoxylin and eosin. For 
necroinflammation and steatosis grading, hematoxylin and eosin stained 
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liver section were ranked as follow:  0 = absent; 1 = sparse or mild; 2 = 
noticeable; 3 = severe. For iron detection, 4 μm sections from each 
sample were stained with Perls’ Prussian blue stain and semi-
quantitatively evaluated under a light microscope as follows: 0 = 
absence of iron laden cells; 1 = rare iron laden cells; 2 = small number of 
iron laden cells; 3 = moderate numbers of iron laden cells; 4 = large 
numbers of iron laden cells. For fibrosis evaluation, 4 μm liver sections 
were stained with Sirius Red stain and evaluated as follows: 0 = absence 
of fibrosis; 1 = mild perisinusoidal fibrosis; 2 = moderate perisinusoidal 
fibrosis. 
4.7 ELISA assay 
Whole wounds were collected at 2, 7, and 12 days after wounding and 
homogenized in 50 mM Tris-HCl, pH 7.5, containing 2 mM EGTA, 1 mM 
PMSF, 100 KU aprotinin, 1% Triton X-100 (all from Sigma-Aldrich, Milano, 
Italy), and complete protease inhibitor cocktail (Roche, Monza, Italy). 
Total proteins were measured by DC Protein Assay, according to 
manufacturer’s instructions (Bio-Rad Laboratories, Segrate, Italy). 
Cytokine levels were measured in accordance with the manufacturer’s 
instructions (R&D Systems, Space, Milano, Italy). A seven-point standard 
curve was used to calculate the concentration of the molecules and PBS 
plus 1% BSA was used as a negative control. Absorbance was measured 
using GloMax® Discover Microplate Reader (Promega, Madison, WI) and 
analyzed using Prism software (version 6.00 for Windows; GraphPad). 
4.8 Flow cytometry and cell sorting 
A single-cell suspension of wounded skin was generated by cutting 
samples into small pieces and digestion in PBS (pH 7.4) supplemented 
with collagenase type I (1 mg/ml; Sigma-Aldrich) and hyaluronidase (125 
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U/ml; Sigma-Aldrich) at 37°C for 1 h, twice. Finally, a single-cell suspension 
was obtained by mechanical separation followed by 100 μm filtration 
and erythrocyte lysis in 0.15 M NH4Cl, 10 nM KHCO3, 1 nM Na4EDTA, pH 
7.2. The following fluorophore-conjugated antibodies were used for 
immunophenotyping and intracellular staining: anti–mouse CD45 
BV605TM (#30-F11; BD Biosciences); anti–mouse Ly6G PE-CF594TM (#1A8; 
BD Biosciences); anti–mouse Ly6C BV421TM (#AL-21; BD Biosciences); 
anti-mouse CD11b PerCP-CyTM5.5 (#M1/70; BD Biosciences); anti-mouse 
F4/80 PE-Cy7TM (#BM8; BioLegend, Campoverde, Milano, Italy); anti-
mouse CD3 APC (#145-2C11 eBioScience, Thermo Fisher); anti mouse 
MHCII BV711 (#M5/114 BD Biosciences); CD206 PE (#C068C2 BioLegend); 
CD195 FITC (CCR3) (#J073E5 BioLegend). Dead cells exclusion was 
performed using LIVE /DEAD fixable Aqua dead cell stain kit (Life 
Technologies, Thermo Fisher) at room temperature for 15 minutes 
following the manufacturer instructions. All gated regions were 
restrictively defined using Fluorescence Minus One as negative control. 
Stained cells were analysed and/or sorted using FACS LSR Fortessa flow 
cytometer (BD Biosciences) or BD FACSAria III cell sorter (BD Biosciences). 
Diva software 20 (Version 8.0.1) (BD Biosciences) was used for data 
acquisition and analysis. The purity of sorted cells was ≥ 98%. 
4.9 Confocal microscopy 
Cryostat sections were incubated in 5% of normal goat (Dako, Milano, 
Italy) or donkey (Sigma-Aldrich) serum, 2% BSA, 0.1% Triton X-100 (Sigma-
Aldrich) in PBS with calcium and magnesium chloride (PBS2+) pH 7.4 for 1 
h at room temperature. Specimens were incubated with the following 
primary antibodies for 2 h at room temperature: rat monoclonal anti-
PDGFR (#4C54, 2 μg/ml; Cell Sciences); rabbit polyclonal anti-collagen I 
(4 μg/ml; AbCam, Euroclone); Cy3-conjugated mouse monoclonal anti-
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α-SMA (#1A4, 2 μg/ml; Sigma-Aldrich); rabbit monoclonal anti-Ki67 
(#D3B5, 1:400; Cell Signaling Technology, Euroclone); rat monoclonal 
anti-CD31 (#MEC 13.3, 1 μg/ml; BD Biosciences); rabbit polyclonal anti-
Lyve-1 (2 μg/ml; AbCam, Euroclone). Sections were then incubated for 1 
h with Alexa Fluor® (488, 594, 647)-conjugated species-specific cross-
adsorbed detection antibodies (Thermo Fisher Molecular Probes). For 
DNA detection, DAPI (300 nM; Thermo Fisher-Molecular Probes) was 
used. After each step, sections were washed with PBS2+ pH 7.4 
containing 0.01% (vol/vol) Tween 20. Sections were mounted with the 
antifade medium FluorPreserve Reagent (EMD Millipore, Vimodrone, 
Italy) and analyzed with an Olympus Fluoview FV1000 laser scanning 
confocal microscope (Olimpus, Segrate, Italy). Immunoreactive areas 
were measured using the computer-assisted digital image processing 
software Image-Pro Plus (version 7.0; Media Cybernetics). The total 
stained area was automatically selected on the basis of RGB color 
segmentation and results are expressed as mean percentage of the 
immunoreactive area ± SD. 
4.10 Quantitative real-time polymerase chain reaction (qRT-PCR) 
Total RNA from liver, spleen, PEC or BMDM was extracted with TRI 
reagent® (Sigma-Aldrich) according to the manufacturer’s instructions. 
The RNA concentration and quality were measured using an optical 
Nanodrop ND2000 spectrophotometer (Thermo Scientific). Total RNA 
(1000 ng) was reverse transcribed into cDNA with Proto Script M-MuLV 
First Strand cDNA Synthesis Kit® (New 21 England Biolabs, Euroclone) and 
the obtained cDNA served as a template for Real-Time PCR, based on 
the TaqMan® methodology (Life Technologies, Thermo Fisher) using a 
Corbett Rotor-Gene 3000 (Quiagen). Thermal cycling parameters were 
40 cycles at 95° C for 15s and 60° C for 1 min. Each sample was amplified 
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in triplicate using the primers reported in Table 2 (Applied Biosystems, 
Thermo Fisher) and the amount of RNA was calculated using the 2-ΔCt 
method. Results were normalized to 18S RNA and the housekeeping 
gene ribosomal protein large P0 (RPLPO) with similar results (in the figures 
only 18S RNA is shown). 
Table 2. List of Primers 
Gene TaqMan gene expression assay ID 
TfR1  Mm00441941_m1  
Fpn Mm01254820_m1  
Rn18s  Mm03928990_g1  
FtH  Mm04336019_g1  
Fam132b  Mm00557748_m1  
Arg1  Mm00475988_m1  
TNFα Mm00443260_g1  
iNOS  Mm00440502_m1  
Hepcidin  Mm04231240_s1  
CD163  Mm00474091_m1  
YM1  Mm00657889_mH  
Alpha SMA Mm00725412_s1 
CCL2 Mm00441242_m1 
CD11b Mm00434455_m1 
COL1-a1 Mm00801666_g1 
COL1-a2 Mm00483888_m1 
HO1 Mm00516005_m1 
IL1a Mm00439620_m1 
IL1b Mm00434228_m1 
IL6 Mm00446190_m1 
TGF-β Mm01178820_m1 
TIMP1 Mm01341361_m1 
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4.11 Western blot and amido black staining 
BMDM and PEC samples were homogenized in 10 mM Tris-HCl, pH 7.0, 1 
mM MgCl2 and the postnuclear supernatant fraction obtained by 
centrifugation at 2000g for 10 minutes was ultracentrifuged at 150000g 
for 20 minutes to pellet crude membrane fractions 70. Equal amounts of 
proteins were separated by SDS-polyacrylamide gels and transferred 
onto Hybond membranes (Amersham Biosciences, Euroclone). Blots 
were incubated with antibodies against FPN (1:250; Alpha Diagnostic, 
DBA, Segrate, Italy) and HRP-conjugated secondary antibodies. The 
proteins were detected using an immunodetection kit (ECL Plus; 
Amersham Biosciences, Euroclone). The results were quantified using 
Image J (v1.45q, NIH, USA). Data were normalized to proteins stained 
with 0.1% w/v amido black solution (Sigma-Aldrich). 
4.12 Statistical analysis 
Results are expressed as mean ± SEM, as specified. Statistical significance 
between groups was assessed by unpaired two-tailed Mann-Whitney test 
or Student’s t test with Prism software (version 6.00 for Windows; 
GraphPad). When more than two groups were present Kruskal-Wallis 
one-factor analysis of variance (ANOVA) test was performed. 
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5. RESULTS 
5.1 Lack of Fpn leads to iron accumulation in macrophages 
Mice carrying the floxed Fpn allele (Fpnfl/fl) 12, were bred to mice 
expressing Cre recombinase under the control of the macrophage-
specific promoter Lysozyme M (LysM) in the C57BL/6J background in 
order to generate mice with specific Fpn inactivation in monocyte–
macrophage cell lineage (Fpnfl/flLysCre/-). A mouse line with Fpn 
inactivation in macrophages driven by the LysM Cre has been previously 
described 71. These mice were maintained on the 129/SvEvTac 
background, whereas we maintained our animals in the C57BL/6 
background by backcrossing for over 10 generations. Since iron 
metabolism can be quite different among various mouse strains 72-74, we 
characterized our mice and compared the phenotype with previously 
published results. Fpnfl/flLysCre/- mice were viable, were born in Mendelian 
ratios, reproduced normally and did not show significant differences in 
body weight compared to Fpnfl/flLys-/-. No evident differences between 
males and females were observed. Histological analysis of the major 
organs showed no differences between the two genotypes. 
Fpn expression in bone marrow derived macrophages (BMDM) and 
peritoneal exudate cells (PEC) was assessed at the mRNA level by qRT-
PCR and at the protein level by western blot: a >90% reduction of Fpn 
expression confirmed the correct gene inactivation (Figure 12A and 12B).  
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Disruption of Fpn in macrophages led to iron accumulation, revealed by 
Perls’ staining, in liver and spleen macrophages of Fpnfl/flLysCre/- mice 
compared to Fpnfl/flLys-/- littermates (Figure 13). 
  
Figure 12. FPN deletion in BMDM  and PEC of Fpnfl/flLysCre/- mice. 
A) The inactivation of Fpn in macrophages was confirmed by qRT-PCRin BMDM and PEC 
of Fpnfl/flLysCre/- micevs littermates Fpnfl/flLys-/-. Results were normalized to the housekeeping 
gene 18S RNA(mean ± SEM of n=50 mice for each group; *** p< 0.0001). 
B) Densitometric quantitation of immunoblot analysis of membrane Fpn in BMDM and PEC 
from Fpnfl/flLys-/- and Fpnfl/flLysCre/-mice. The blots were stained with amido black to assess 
equal protein loading (mean ± SEM of n=20 mice for each group; *** p< 0.0001). 
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5.2 Lack of Fpn leads to transient anemia at 3 weeks after birth 
As compared to control Fpnfl/flLys-/- littermates, Fpn deletion in 
macrophages of Fpnfl/flLysCre/- mice resulted in a significant decrease in 
hemoglobin (Hb) levels and hematocrit (Hct) at 3 weeks after birth. 
Thereafter, both parameters rapidly returned to normal levels and 
remained almost unaltered until 18 weeks (Figure 14). On the contrary, 
serum iron levels do not show significant differences (Figure 14). 
 
 
 
 
 
Figure 13. Fpn deletion causes iron accumulation in macrophages of Fpnfl/flLysCre/- 
mice. 
Histology of Perls’ Prussian blue iron staining in paraffin sections of spleen from Fpnfl/flLys-/- 
and Fpnfl/flLysCre/-mice. A semi-quantitative evaluation of Perls’ iron staining in spleen and 
liver (performed as reported in Materials and Methods) is shown on the right. Data are 
presented as mean ± SEM of n= 6 for each group; *** p< 0.0001, ** p< 0.001. Magnification 
40X 
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The expression of HAMP, the main regulator of systemic iron metabolism, 
showed age-related variations but was not different in Fpnfl/flLysCre/- mice 
compared to their control littermates (Figure 15). Accordingly, the 
expression of Fam132b mRNA encoding for erythroferrone, the erythroid 
regulator of HAMP 75, did not show significant differences (Figure 15). 
 
 
 
Figure 14. Fpn deletion in macrophages causes anemia in pups of Fpnfl/flLysCre/- 
mice. 
Hb levels, Hct and serum iron in 3, 6, 12, 18 week old mice. Hb and Hct showed a significant 
decrease at weaning, but returned to normal levels at 6 weeks and remained almost 
unaltered until 18 weeks (mean ± SEM of n=50 mice for each group; **p < 0.001). 
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5.3 Fpn deletion in macrophages compromises hair follicle growth 
and causes alopecia 
Fpnfl/flLysCre/- mice showed diffuse alopecia at birth without the 
involvement of the head; alopecia was present in both male and female 
mice and lasted until the fourth week of age (Figure 16A). Histological 
analysis in 3-week-old mice showed a moderate to severe coalescing 
dilatation of hair follicles, which contain remnants of hair shafts and 
keratin, and slight achantosis of the superficial epidermis (Figure 16A). 
Alopecia gradually disappeared and hair started to regrowth 2 weeks 
after weaning. Histological analysis showed that, despite hair regrowth, 
minor skin alterations were still detectable in adult (12 weeks) 
Fpnfl/flLysCre/- mice, with reduced number of hair follicles, multifocal areas 
of hair shafts rarefaction, and thin hypodermis with an apparent increase 
of adipose tissue (Figure 16B). Taken together, these results suggest that 
Figure 15. Expression of HAMP and Fam132b did not show significant differences 
between Fpnfl/flLysCre/- mice and controls. 
HAMP and Fam132b expression of 3, 6, 12 and 18 week old mice. mRNA levels were 
measured by qRT-PCR and normalized to the housekeeping gene 18S RNA (mean ± SEM of 
n=10 mice for each group). 
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Fpn deletion in macrophages causes severe alterations of the hair follicle 
and of the epidermis. 
5.4 Alopecia is not a direct consequence of anemia 
The gradual disappearance of alopecia after weaning raised the 
possibility of a compensatory role provided by the switch in the diet, 
thanks to the higher iron availability. To better understand if alopecia in 
Fpnfl/flLysCre/- mice was a local reflection of systemic iron deficiency or a 
local effect of iron sequestration in macrophages, we determined the 
effect of an iron-restricted diet on the hair growth of both mice 
populations. We monitored hematologic parameters and alopecia in 
Figure 16. Transient alopecia is present in Fpnfl/flLysCre/- mice. 
A) Appearance of 3-week-old Fpnfl/flLys-/- (left) and Fpnfl/flLysCre/- (right) mice and histology 
(dorsal area) of the same mice. Tissue sections were stained with hematoxylin and eosin. 
Magnification 10X, in the inset 20X. 
B) Histology of the skin (dorsal area) of adult (12-week-old) mice. Tissue sections were 
stained with hematoxylin and eosin. Magnification (10X). 
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pups fed for their first 3 weeks of life by dams kept on iron-deficient diet 
and then exposed to low iron diet for 2 additional weeks after weaning 
(Figure 17A). Until week 5, both Fpnfl/flLysCre/- and control littermates were 
anemic but Hb, Hct and serum iron levels were always significantly lower 
in animals lacking macrophage Fpn (Figure 17B and 17C). 
 
 
 
 
Figure 17. Alopecia in Fpnfl/flLysCre/- mice is not related to anemia. 
A) Schematic overview of the feeding protocol: pups were fed by dams kept on iron-
deficient diet for 3 weeks until weaning and then maintained on low iron diet for 2 
additional weeks followed by normal diet. 
B) Hb and Hct levels in 3-8-week-old mice (mean ± SEM of n=10 mice for each group; *** p < 
0.0001, ** p < 0.001). The histogram at the bottom shows the degree of alopecia at different 
time points. *** p < 0.0001, **p < 0.001. 
C) Hb, Hct and serum iron levels in 3-18-week-old mice (mean ± SEM of n=10 mice for each 
group; ** p < 0.001). 
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Mice with loss of macrophage Fpn were grossly affected by diffuse 
alopecia of the trunk, whereas Fpnfl/flLys-/- mice did not develop alopecia 
during the period of exposure to the low iron diet (Figure 17B). Moreover, 
even exposing control mice to the iron deficient diet for 11 weeks did not 
trigger the appearance of alopecia. In Fpnfl/flLysCre/- mice, after the 
reintroduction of a normal diet, serum iron levels, Hb and Hct returned to 
normal levels 2 weeks before the restoration of normally haired skin 
(Figure 17B), thus indicating that alopecia and hypoferremia/anemia are 
not directly associated. 
As expected, liver HAMP expression was repressed by the iron-deficient 
diet, but with no differences between Fpnfl/flLysCre/- mice and their control 
littermates (Figure 18). A significant increase in Fam132b expression was 
Figure 18. Expression of HAMP and Fam132b did not show significant differences 
between Fpnfl/flLysCre/- mice and controls. 
HAMP and Fam132b mRNA levels in liver and spleen, respectively, of 3-18 weeks old mice. 
Expression in 3-week-old mice fed the normal diet is shown in comparison. mRNA levels were 
measured by quantitative RT-PCR and normalized to the housekeeping gene 18S RNA 
(mean ± SEM of n = 10 mice for each group; ** p < 0.001, *** p < 0.0001). 
41 
 
found in Fpnfl/flLysCre/- pups at 3 weeks (Figure 18), indicative of higher 
erythropoietic activity. After week 5, with the introduction of the normal 
diet, both HAMP and Fam132b expression returned to normal levels 
without differences between Fpnfl/flLysCre/- mice and controls (Figure 18). 
Histological analysis confirmed that in Fpnfl/flLysCre/- mice alopecia was 
associated with severe follicular keratosis with intraluminal accumulation 
of keratin, distorted hair shafts and subsequent dilation of the hair 
follicles. Conversely, no relevant gross and histopathological changes 
were found in the dorsal haired skin of the Fpnfl/flLys-/- mice maintained in 
the same dietary conditions (Figure 19A) . In both mice populations, skin 
histology showed that hair follicles were in the anagen stage, but in 
Fpnfl/flLysCre/- mice hair shafts did not exit the follicular ostia and follicular 
Figure 19. Fpnfl/flLys-/- mice exposed to iron-deficient diet did not develop 
alopecia. 
A) Representative histology of the skin (dorsal area) of 3-week-old Fpnfl/flLys-/-and 
Fpnfl/flLysCre/-mice maintained with an iron deficient diet. Tissue sections were stained with 
hematoxylin and eosin. Magnification 20X. 
B) Representative histology of the skin (dorsal region) after 5 weeks of iron deficient diet 
plus 2 weeks of normal diet. Tissue sections were stained with hematoxylin and eosin. 
Magnification 10X, in the insets 20X. 
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dilation, increased epidermal hyperplasia, and increased dermal 
inflammation were observed (Figure 19B). 
We then investigated cell proliferation in hair bulb by analysing the 
expression of the cell proliferation marker Ki67 by confocal microscopy. 
Figure 20 shows a significant decrease of Ki67 expression in epithelial cells 
of the hair bulbs of 3-week-old Fpnfl/flLysCre/- mice compared to controls. 
Figure 20. Decreased proliferation in cutaneous hair follicles of Fpnfl/flLysCre/-mice. 
A) Expression and localization of Ki67 in cutaneous tissue of Fpnfl/flLys-/- and Fpnfl/flLysCre/- mice 
was assessed by confocal microscopy. Bars, 100 μm. Magnification 40X. 
B) Quantitation of confocal images, data are presented as mean ± SEM (5-9 field of 
vision/mouse, 3 mice/group); *** p< 0.0001 
A 
B 
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Interestingly, in the same cells we found a strong increase of TfR1 
expression, indicative of cellular iron deprivation (Figure21). Conversely, 
macrophages (F4/80+ cells) did not expressed TfR1, confirming the iron-
loaded status of these cells in Fpnfl/flLysCre/- mice. The great number of 
F4/80 positive cells in the skin (Figure 21) supports the critical role of 
macrophages in the homeostasis of this tissue. 
 
 
Figure 21. Increased iron demand in cutaneous hair follicles of Fpnfl/flLysCre/-mice. 
A) Expression and localization of TfR1 and F4/80 in cutaneous tissue of Fpnfl/flLys-/- and 
Fpnfl/flLysCre/- mice was assessed by confocal microscopy. Magnification 20X. 
B) Quantitation of confocal images, data are presented as mean ± SEM (3 mice/group , 5-9 
field of vision/mouse); *** p< 0.0001 
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Taken together, these results suggest that iron retention in resident 
macrophages has detrimental effects on tissue homeostasis by reducing 
iron availability for hair follicle cells and consequently inhibiting their 
proliferation. 
5.5 Fpn deletion in macrophages affects cutaneous wound healing 
To test the hypothesis that macrophage derived iron could be an 
important element in the context of tissue homeostasis, particularly under 
conditions of increased cell proliferation, we set-up a cutaneous wound 
healing model. After performing a full thickness incisional cutaneous 
wound, we monitored the entire time course of the repair process: the 
early-inflammatory (2 days post injury [dpi]), middle-proliferative (7 dpi), 
and late-remodeling phases (12 dpi). Macroscopical analysis showed 
that in Fpnfl/flLysCre/- mice the process of wound closure was considerably 
delayed as compared to wild-type littermates, with significantly wider 
lesions at all time points and a lag of 3-5 days in the wound closure 
(Figure22). 
 
Figure 22. Skin repair is delayed 
in Fpnfl/flLysCre/-mice. 
Kinetic analysis of skin excisional 
wound areas. Values represent 
mean ± SEM of n= 24 for each 
group; * p< 0.01. One 
representative experiment (n= 6 
mice/group) out of 4 is shown. The 
inset shows representative 
macroscopic images of Fpnfl/flLys-/- 
and Fpnfl/flLysCre/- mice skin wounds 
at 7 dpi. 
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Histological analysis supported this observation, since Fpnfl/flLysCre/- mice 
displayed a more prolonged inflammatory response and delayed 
granulation tissue formation, whereas mononuclear cells and 
granulocytes were unchanged (Figure 23). 
 
 
 
 
 
Figure 23. Fpnfl/flLysCre/-mice displayed prolonged inflammatory response and 
delayed granulation tissue formation. 
Histological grading of wound healing, based on separate evaluation of distinct features 
of wound healing process, at 2, 7, 12 dpi. IGT: Immature granulation tissue, MGT: mature 
granulation tissue. The semiquantitative score was defined as described in Supplemental 
Table 1; n= 12 for each group; *** p < 0.0001, ** p < 0.001, * p < 0.01. 
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5.6 Fpn deletion effectively causes iron accumulation in wound 
macrophages of Fpnfl/flLysCre/- mice 
To characterize the functional impact of Fpn in the wound healing 
process, we first investigated its expression in FACS-sorted macrophages 
from wounds of control mice: Fpn mRNA levels were quite low in the 
inflammatory phase and progressively increased during the middle-late 
phases of repair (Figure 24), suggesting a predominant role of Fpn in the 
final phase of wound repair. The analysis of other iron related genes 
showed an increased expression of TfR1 and a decrease of Ft during the 
middle-late phases in macrophages obtained by wounded skin of 
control mice, but not from those obtained from Fpnfl/flLysCre/- mice, as a 
consequence of iron accumulation in these cells (Figure 24). 
Accordingly, iron accumulation in macrophages localized in wounds of 
Fpnfl/flLysCre/-  mice was confirmed by histological analysis (Figure 25).  
Figure 24. Iron release causes increased expression of TfR1 and a decrease of Ft in 
macrophages of control mice, but not of Fpnfl/flLysCre/-mice. 
Macrophages (CD45+/CD11b+/Ly6C+/F4/80+) were sorted by FACS from wounded skin 
tissue of 8 animals/group at 2, 7 and 12 dpi from Fpnfl/flLys-/- and Fpnfl/flLysCre/- mice. Fpn, 
TfR1 and H-ferritin (FtH) mRNA expression was assessed by qRT-PCR and normalized to the 
housekeeping gene 18S RNA. Data are presented as mean ± SEM; * p< 0.01, **p<0.001, *** 
p < 0.0001 
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HAMP-dependent Fpn modulation does not seem to play a role in 
wound healing, as liver HAMP expression showed no differences 
between Fpnfl/flLysCre/- mice and controls during the entire time course of 
the wound repair process (Figure 26). 
5.7 Iron retention in macrophages has no impact on inflammatory 
response in cutaneous wound healing 
As it has been reported that iron accumulation in macrophages might 
favour the expression of inflammatory mediators 51,71,76,77, we evaluated 
the levels of inflammatory cytokines in wound lysates, but we did not 
detect significant differences between the two mouse lines at any time 
point, with the only exception of increased levels of CXCL1 at 7 dpi in 
Fpnfl/flLysCre/- mice (Figure 27). 
Figure 25. Fpn deletion causes 
iron accumulation in 
macrophages localized in 
wounds of Fpnfl/flLysCre/- mice. 
Representative histology of Perls’ 
Prussian blue iron staining of dorsal 
skin samples at 12 dpi in Fpnfl/flLys-/- 
and Fpnfl/flLysCre/- mice. 
Magnification 40X. A semi-
quantitative evaluation of Perls’ iron 
staining is shown on the right. n= 6 
for each group; *** p < 0.0001. 
Figure 26. HAMP-dependent Fpn 
modulation is not involved in wound 
healing. 
HAMP expression in liver of mice untreated 
and at 2, 7, 12 dpi. mRNA levels were 
measured by quantitative RT-PCR and 
normalized to the housekeeping gene 18S 
RNA. Data are presented as mean ± SEM of 
n=12 mice for each group. 
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Figure 27. Cytokines levels in wound skin are not altered in Fpnfl/flLysCre/-mice. 
CCL2, CXCL1, CXCL2, IL-1β, TGF-β, TNFα and VEGFα protein levels in wound lysates from 
Fpnfl/flLys-/- and Fpnfl/flLysCre/- mice were assessed by ELISA at different dpi after skin injury. At the 
time points not shown, the levels of the respective cytokine were below the detection limit of 
the assay. Data are presented as mean ± SEM; n=10 mice for each group; * p < 0.01. 
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Given the role of leukocytes in the orchestration of tissue repair 3, it was 
important to establish whether the defective wound healing observed in 
Fpnfl/flLysCre/- mice was the result of altered leukocyte recruitment. 
Analysis of leukocyte subsets showed that neutrophils (Ly6G+ cells) and 
eosinophils (CCR3+ cells) were abundant at 2 and 7 dpi and decreased 
thereafter (12 dpi), whereas an inverse trend was evident for T cells 
(CD3+ cells), which significantly increased at late time-points (12 dpi) 
(Figure 28). These cell accumulation kinetics, which are typical of skin 
wound healing 43, showed no differences in Fpnfl/flLysCre/- mice compared 
to controls, indicating that Fpn deletion in macrophages has no impact 
on leukocyte recruitment and activation in the wound. 
 
Figure 28. Wound infiltrating leukocytes are not altered in Fpnfl/flLysCre/-mice. 
Frequencies of neutrophils (CD11b+/Ly6G+), eosinophils (CD11b+/CCR3+) and T lymphocytes 
(CD3+) on CD45+ cells. Dots and black lines represent single animals and the mean ± SEM, 
respectively; n=10 mice for each group; * p < 0.01. 
 
Macrophages (F4/80+ cells) showed a trend similar to the one observed 
for T cells: a significant increase at 12 dpi (Figure 29). Since iron 
accumulation in macrophages could interfere with the polarization 
process during the healing process 29, we next investigated the 
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distribution of the different macrophage polarized populations during the 
time course of wound healing. As expected, FACS analysis showed an 
increase in macrophages expressing an M1 profile (MHCII+/CD206-) in 
the middle-proliferative phase, followed by a wave of macrophages 
expressing an M2 profile (MHCII-/CD206+) in the late-remodeling phase, 
but no difference was found between Fpnfl/flLysCre/- mice and their 
control littermates (Figure 29). 
 
 
 
Figure 29. Fpn deletion does not modify macrophage polarization in Fpnfl/flLysCre/-mice. 
Frequencies of macrophages (CD11b+/F4/80+) on CD45+ cells; frequencies of M1 
(MHCII+/CD206-) and M2 (MHCII-/CD206+) polarized macrophages on total live macrophages. 
Dots and black lines represent single animals and the mean ± SEM, respectively; n=10 mice for 
each group; * p < 0.01. 
To further investigate this aspect, we evaluated the effect of Fpn 
deletion on the expression of polarization markers in BMDM exposed to 
polarization stimuli in vitro, but again no difference was observed for 
neither M1 (iNOS and TNFα) or M2 (Arg1 and YM1) markers between 
Fpnfl/flLysCre/- and Fpnfl/flLys-/- BMDM (Figure 30). These results indicated 
that, in this model, iron retention in macrophages has no impact on 
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leukocyte recruitment and activation as well as macrophage 
polarization, and the delay in wound closure is not a consequence of 
unaltered inflammatory component of the healing process. 
 
Figure 30. Fpn deletion does not modify macrophage polarization in BMDM derived 
from Fpnfl/flLysCre/-mice and polarized in vitro. 
BMDMs from Fpnfl/flLys-/- and Fpnfl/flLysCre/-  mice were polarized to M1 and M2 macrophages 
and relative iNOS, TNFα, Arg1 and YM1 mRNA levels were measured by qRT-PCR at 24 hours; 
results were normalized to the housekeeping gene 18S RNA (mean ± SEM of n=12 mice for 
each group; *** p < 0.0001, ** p < 0.001, * p < 0.01). 
5.8 Fpn deletion in macrophages affects stromal cells during 
cutaneous wound healing 
Since Fpn deletion in macrophages did not alter the inflammatory 
processes of wound healing, we then evaluated whether the defective 
iron release could affect stromal cells in the wound tissue. Confocal 
analysis at 7 dpi showed reduced expression in Fpnfl/flLysCre/- mice, as 
compared to control littermates, of blood (CD31) and lymph vessel 
(Lyve-1) endothelium markers (Figure 31). 
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Figure 31. Vessel and stromal cells are reduced in Fpnfl/flLysCre/-mice. 
Expression of CD31, Lyve-1, collagen-1, PDFGR, αSMA, Ki67 after skin wounding at 7 dpi was 
assessed by confocal microscopy and the positive area expressed as %. Each circle represents 
a single confocal image (5-9 field of vision/mouse, 6 mice/group; *** p< 0.0001, ** p< 0.001). 
Representative confocal microscopy images are shown. Bars, 100 μm. Magnification 40X. 
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This was accompanied by decreased expression of PDGFRα, a marker of 
mesenchymal cells, and lower levels of collagen I and αSMA, which are 
markers of activated fibroblasts and myofibroblasts, respectively (Figure 
31). Moreover, loss of macrophage Fpn impaired cell proliferation, as 
shown by decreased Ki67 expression (Figure 31). Taken together, these 
results indicate that, though it does not interfere with immune cells 
recruitment and local activation, Fpn deletion in macrophages impairs 
blood vessels formation and stromal cells proliferation, leading to 
delayed skin repair. 
5.9 Fpn deletion in macrophages does not affect steatohepatitis 
induced by MCD diet 
After cutaneous wound healing, another useful model we decided to 
explore was liver fibrosis. To investigate how macrophage derived iron 
could influence this process, we set up a model of liver fibrosis via the 
widely used MCD diet model, which causes a liver injury similar to human 
NAFLD 78. Choline deficiency induces lipid accumulation in the liver by 
impairing the synthesis of very low-density lipoprotein (VLDL) 79, an effect 
similar to methionine deficiency, which also causes oxidative stress and 
contributes to fibrosis progression 80. 
In line with the results showed above (Figure 13), iron accumulation, 
revealed by Perls’ staining, was evident in liver macrophages of 
Fpnfl/flLysCre/- mice compared to Fpnfl/flLys-/- littermates, and the staining 
was not significantly affected by exposure to the control or MCD diet 
(Figure 32). 
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As expected, animals exposed to the MCD diet presented a 3 to 5-fold 
increase in the levels of ALT and AST compared to animals fed the 
control diet (Figure 33). Interestingly, levels of both AST and ALT were 
significantly lower in Fpnfl/flLysCre/- mice fed the MCD diet compared to 
Fpnfl/flLys-/- littermates exposed to the same diet, indicating a less severe 
cell damage(Figure 33). 
Figure 32. Fpn deletion causes iron 
accumulation in liver macrophages 
of Fpnfl/flLysCre/- mice. 
Semi-quantitative evaluation of Perls’ 
iron staining. n= 12 for each group; *** p 
< 0.0001. 
Figure 33. MCD diet in Fpnfl/flLysCre/-mice causes less severe liver damage. 
At the time of killing, blood was drawn and plasma levels of total protein ALT and 
AST were measured. Data are presented as mean ± SEM; * p< 0.01, **p<0.001, *** p 
< 0.0001. 
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We then tried to further investigate this aspect by performing histological 
analysis of liver sections from animals exposed to both control and MCD 
diets. As expected, when fed a control diet the livers of Fpnfl/flLysCre/- mice 
had a histological appearance indistinguishable from that of Fpnfl/flLys-/- 
mice, and both showed no signs of steatohepatitis or fibrosis (Figure 34). 
On the contrary, the MCD diet produced severe steatosis and 
inflammation, but without significant differences between Fpnfl/flLysCre/- 
mice and control mice (Figure 34A). Blinded semi-quantitative evaluation 
of necro-inflammation and steatosis scores by an expert 
anatomopathologist confirmed this result (Figure 34B). 
 
Figure 34. Steatohepatitis induced by MCD diet is not affected by Fpn deletion in 
macrophages in Fpnfl/flLysCre/-mice. 
A) Liver histology representative of the inflammatory and steatosis scores. Tissue sections were 
stained with hematoxylin and eosin staining. Magnification 10X. 
B) Histological grading of hepatic inflammation and steatosis: 0 = absent; 1 = mild; 2 = 
moderate; 3 = severe. Data are presented as mean ± SEM. 
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5.10 Iron retention in macrophages does not affect liver fibrosis 
induced by MCD diet 
In the attempt to better characterize the role of macrophage iron in 
these settings, we evaluated the levels of cytokines with inflammatory 
and fibrogenic functions in mice fed the MCD diet. The expression of the 
pro-inflammatory mediators TNFα, IL-6 and CCL2did not show significant 
differences between Fpnfl/flLysCre/- mice and control littermates (Figure 
35). These data suggest that Fpn deletion in macrophages does not 
affect the inflammatory response to liver damage, a result that confirms 
what we observed in the cutaneous wound healing model. 
Similarly, no significant differences were observed in the expression of the 
fibrogenic cytokines TGF-β and TIMP-1 and in the levels of collagen I and 
αSMA (markers of activated fibroblasts and myofibroblasts respectively) 
(Figure 35). 
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Figure 35. Inflammatory and fibrotic mediators in liver are not altered in Fpnfl/flLysCre/-
mice. 
TNFα, IL-6, CCL2, TGF-β, TIMP-1, αSMA and COL1-a mRNA levels in liver from Fpnfl/flLys-/- and 
Fpnfl/flLysCre/- mice. mRNA levels were measured by quantitative RT-PCR and normalized to the 
housekeeping gene 18S RNA (mean ± SEM of n = 10 mice for each group; ** p < 0.001). 
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Histological analysis of liver sections using Sirius red staining to assess 
collagen deposition (Figure 36A) gave similar results: animals exposed to 
the control diet had no sign of fibrosis, while mice fed on MCD diet 
showed mild to moderate perisinusoidal fibrosis, but without significant 
differences between Fpnfl/flLysCre/- mice and control littermates. The 
results were confirmed by a blinded evaluation (Figure 36B). 
 
Figure 36. Fibrosis induced by MCD diet is not affected by Fpn deletion in 
macrophages in Fpnfl/flLysCre/-mice. 
A) Liver histology representative of the fibrosis scores. Tissue sections were stained with Sirius red 
staining. Magnification 10X. 
B) Histological grading of hepatic fibrosis: 0 = absence of fibrosis; 1 = mild perisinusoidal fibrosis; 
2 = moderate perisinusoidal fibrosis. Data are presented as mean ± SEM. 
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In summary, these results indicate that, in this liver injury model, there are 
no differences in the inflammatory response to liver damage and in 
fibrogenesis. The different levels of transaminases are probably due to a 
different susceptibility of Fpnfl/flLysCre/- mice to liver damage, a result that 
should be further investigated, maybe using another model of liver 
fibrosis. 
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6. DISCUSSION 
In line with the increasing awareness that macrophages have an 
important trophic role in addition to their immunological function 81, the 
studies reported in this thesis were mainly focused on exploiting a mouse 
model with Fpn inactivation in macrophages to explore the role of iron 
release from macrophages in tissue homeostasis and regeneration. The 
role of macrophages of the reticuloendothelial system as a source of iron 
for erythroid progenitor cells is well established 82, but we hypothesized 
for macrophages a role as “local iron redistributors” in other tissues, 
where macrophages manage iron availability for neighbouring cells. 
Since iron metabolism can be quite different among various mouse 
strains 72-74, we first characterized our model in which macrophage Fpn 
was inactivated in C57BL/6J mice and compared the phenotype with 
previously published results obtained in the 129/SvEvTac background 71. 
Actually, we found significant differences also in the absence of any 
pathological stimulus (see below). Although it is known that the 
efficiency of the Cre/Lox system is not complete, Fpn deletion in 
macrophages of Fpnfl/flLysCre/- mice was able to cause the expected iron 
accumulation in spleen macrophages. Other types of macrophages, 
such as liver Kupffer cells and BMDM, showed the same increase in iron 
deposition. Iron retention was accompanied by a significant decrease in 
serum iron and hence by lower Hb levels and Htc at3 weeks after birth. 
However, all blood parameters rapidly returned to normal levels after 
weaning and remained almost unaltered until 18 weeks, indicating a 
compensatory effect by increased absorption of dietary iron. 
Notably, Fpnfl/flLysCre/- mice showed diffuse alopecia at birth without the 
involvement of the head. This phenotype has not been reported in mice 
lacking macrophage Fpn maintained on the 129/SvEvTac background, 
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thus reinforcing the concept that some aspects of iron homeostasis are 
strain-specific. In the attempt to better characterize this condition, we 
observed a moderate to severe coalescing dilatation of hair follicles, 
which contain remnants of hair shafts and keratin, and slight achantosis 
of the superficial epidermis. Hair started to regrow 2 weeks after weaning 
and was full regrown at four weeks of age. Histological analysis showed 
that minor skin alterations were still detectable in adult mice with normal 
hair. These observations indicating that Fpn deletion in macrophages 
causes severe alterations of the hair follicle and epidermis are in line with 
similar hair and skin lesions observed in mice with altered expression of 
other proteins of iron metabolism 83-85 and indicate the key role of iron in 
these settings, though in the above mentioned studies the presence of 
systemic iron deficiency did not allow the authors to distinguish the effect 
of low systemic iron levels from the actual local availability of 
macrophage-derived iron. To better understand if alopecia in our mice 
was a consequence of systemic iron deficiency or a local effect of iron 
sequestration in macrophages, we determined the effect of an iron-
restricted diet on hair growth of both mice populations. During induction 
of iron-deficiency both Fpnfl/flLysCre/- and control littermates suffered of 
iron-dependent anemia, but only mice with loss of macrophage Fpn 
were affected by alopecia, whereas control mice, no matter how long 
they were fed the low iron diet, never lost hair. Furthermore, no relevant 
gross and histopathological changes were found in the dorsal haired skin 
of control mice maintained in prolonged iron deficiency. Accordingly, 
after the reintroduction of a normal diet, serum iron, Hb and Hct of 
Fpnfl/flLysCre/- mice returned to normal levels 2 weeks before the 
restoration of normally haired skin, thus confirming that alopecia and 
hypoferremia/anemia are not directly associated. These results raised the 
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question of which functions can be compromised by iron scarcity in 
epidermal cells. In keeping with previous results showing that iron 
released via Fpn from human in vitro differentiated macrophages 
supports in vitro cell proliferation 29, an important role for the numerous 
skin macrophages could be the release of sufficient iron for the 
multiplication of growing cells in the microenvironment. In fact, the 
expression of the proliferation marker Ki67 was significantly decreased in 
fast growing epithelial cells of the hair bulbs of 3-week-old Fpnfl/flLysCre/- 
mice, compared to controls. The demonstration that TfR1 expression, 
indicative of low iron levels, is increased in the same epithelial follicle 
cells if tissue macrophage lack Fpn, supports the conclusion that Fpn-
dependent iron release from macrophages is essential for correct tissue 
homeostasis, in particular to sustain the rapid growth of hair follicle cells. 
Notably, a recent study has shown that macrophages are part of the 
stem cell niche in various tissues 86 and the results reported here raise the 
possibility that macrophage dependent iron metabolism could have a 
specific role in stem cell niches.  
These conclusions were confirmed by our data obtained using a 
cutaneous wound healing model, a prototypic situation of tissue repair in 
which macrophages play a key role 38. In line with the importance of 
macrophage iron release for tissue homeostasis, we observed in 
Fpnfl/flLysCre/- mice a considerable delay in the process of wound healing, 
with a lag of 3-5 days in the wound closure and delayed granulation 
tissue formation. Given the role of macrophages in the development of 
inflammation, it was important to establish whether the defective wound 
healing observed in Fpnfl/flLysCre/- mice was the result of an altered 
inflammatory response. Analysis of macrophage production of 
inflammatory molecules, of content of different leukocyte subsets and of 
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macrophages polarization capability showed no differences in 
Fpnfl/flLysCre/- mice compared to controls, indicating that the delay in the 
process of wound closure that we observed is not a consequence of a 
different inflammatory response. To date, the role of iron in macrophage 
activity during inflammation is unclear: an increased inflammatory 
response was found in iron-depleted macrophages 87, but not in equally 
iron-deficient macrophages from HFE-/- mice model 88. Other studies 
showed that iron chelation reduced the synthesis of proinflammatory 
cytokines in isolated macrophages 89, whereas TNFα and IL-6 production 
were increased in Fpn-deficient macrophages with iron accumulation71. 
These contradictory results may be related to the different experimental 
models, the heterogeneity of macrophages, the exposure to different 
sources of iron and stimuli, etc. In our model, iron accumulation in 
macrophages did not aggravate the inflammatory response in wound 
healing, a finding in line with a recent study showing that iron did not 
increase M1 polarization of RAW264.7 macrophages 90. 
We then hypothesized that the disruption of iron export from 
macrophages due to Fpn deficiency could delay wound healing by 
preventing nearby mesenchymal and stromal cells from receiving 
adequate iron supply for proper proliferation and differentiation. In line 
with the higher Fpn expression in M2 macrophages compared to M1 29,32, 
the lack of macrophage Fpn should exert its major effects in the late 
phase of repair. Indeed, in the late stages, normal M2 macrophages 
export iron through enhanced Fpn expression, whereas Fpnfl/flLysCre/- mice 
macrophages accumulate iron with concomitant induction of Ft and 
repression of TfR1 expression. In fact, the lower fibrosis score and the 
decreased expression of collagen-1, αSMA and PDGFRα showed that in 
Fpnfl/flLysCre/- mice the stromal component is compromised. Moreover, 
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our results show that macrophage iron is also essential for the 
development of both lymphatic and blood vascular network in face of 
unchanged levels of angiogenic and fibrogenic factors like VEGF and 
TGF-β. Finally, loss of macrophage Fpn impaired cell proliferation, as 
shown by decreased Ki67 expression. Taken together, these results 
indicate that, though it does not interfere with immune cells recruitment 
and local activation, Fpn deletion in macrophages impairs blood vessels 
formation and stromal cells proliferation, leading to delayed skin repair. 
In summary, we showed that the correct Fpn-iron supply from 
macrophages is essential for tissue homeostasis both in physiological and 
pathological conditions in a tissue, the skin characterized by a fast cell 
growth 91. 
Given the results we obtained from cutaneous wound healing, we 
decided to explore another useful model of tissue repair: liver fibrosis, a 
process in which macrophages play a key role 54,55. To investigate how 
macrophage derived iron could influence this process, we used the 
MCD diet model, which causes a liver injury similar to that occurring in 
human NAFDL. The first results obtained in animals exposed to the MCD 
diet showed that the levels of both ALT and AST in Fpnfl/flLysCre/- were 
significantly lower compared to controls, indicating a less severe cell 
damage. Then, we tried to investigate the possible consequences of this 
difference by evaluating inflammation and steatosis. However, no 
significant differences between Fpnfl/flLysCre/- mice and control mice 
exposed to the same diet were found when we analysed liver histology 
and measured the expression of various inflammatory cytokines, 
although a trend toward lower levels of TNFα and IL-6 mRNA was evident. 
These data suggested that Fpn deletion in macrophages does not affect 
the inflammatory response to liver damage, confirming the results in the 
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cutaneous wound healing. We then decided to explore the effect of Fpn 
deletion in macrophages on stromal cells and ECM deposition by 
analysing specifically the fibrosis process. No significant differences were 
observed in the expression of the fibrogenic cytokines TGF-β and TIMP-1 
and in the levels of collagen I and αSMA. Moreover, staining of liver 
sections for collagen confirmed the lack of statistically significant 
differences in fibrosis score between Fpnfl/flLysCre/- mice and controls. In 
summary, these preliminary results show no differences either in the 
inflammatory response nor in the activity of stromal cells between 
Fpnfl/flLysCre/- mice and controls. The only significant difference, 
represented by transaminases levels, is probably attributable to a 
resistance of our model to hepatic injury, rather than an altered 
inflammatory/fibrotic response. 
In conclusion, the different results we observed in the two models should 
be further investigated, to better elucidate the diversity between the 
effect of iron retention in macrophages in the cutaneous wound healing 
and in the process of hepatic fibrosis. Particularly, the cause of the 
hypothetical resistance of our model to liver damage should be 
explored. In this respect, in addition to performing other experiments with 
the MCD diet model, we are considering to use another model of liver 
fibrosis. 
Despite these inconsistencies that should be further explored, it seems 
possible to conclude that the results reported in this thesis indicate that 
the macrophage trophic function in skin homeostasis and healing is iron 
and Fpn-dependent. Interestingly, a requirement for iron provided by 
macrophages similar to the one we observed in the skin has been 
recently described for the repair of skeletal muscle cells 92.Therefore, iron 
should be added to the list of trophic mediators produced by 
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macrophages that stimulate the growth, differentiation and activity of 
neighboring parenchymal and stromal cells in order to maintain tissue 
homeostasis or promote repair.  
 
 
67 
 
7. BIBLIOGRAPHY 
1. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu 
Rev Pathol. 2011;6:425-456. 
2. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 
2011;117(17):4425-4433. 
3. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair 
and regeneration. Nature. 2008;453(7193):314-321. 
4. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 
2007;69:69-85. 
5. Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L. Mechanisms of 
mammalian iron homeostasis. Biochemistry. 2012;51(29):5705-5724. 
6. Cairo G, Bernuzzi F, Recalcati S. A precious metal: Iron, an essential 
nutrient for all cells. Genes Nutr. 2006;1(1):25-39. 
7. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. 
Science. 2012;338(6108):768-772. 
8. Muckenthaler MU, Rivella S, Hentze MW, Galy B. A Red Carpet for 
Iron Metabolism. Cell. 2017;168(3):344-361. 
9. Haldar M, Kohyama M, So AY, et al. Heme-mediated SPI-C 
induction promotes monocyte differentiation into iron-recycling 
macrophages. Cell. 2014;156(6):1223-1234. 
10. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-
1741. 
11. Theil EC. Iron, ferritin, and nutrition. Annu Rev Nutr. 2004;24:327-343. 
12. Donovan A, Lima CA, Pinkus JL, et al. The iron exporter 
ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 
2005;1(3):191-200. 
13. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular 
iron efflux by binding to ferroportin and inducing its internalization. 
Science. 2004;306(5704):2090-2093. 
14. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron 
regulatory peptide hepcidin is regulated by anemia, hypoxia, and 
inflammation. J Clin Invest. 2002;110(7):1037-1044. 
68 
 
15. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. 
Hepcidin, a putative mediator of anemia of inflammation, is a type 
II acute-phase protein. Blood. 2003;101(7):2461-2463. 
16. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin 
expression through STAT3. Blood. 2006;108(9):3204-3209. 
17. Zoller EE, Lykens JE, Terrell CE, et al. Hemophagocytosis causes a 
consumptive anemia of inflammation. J Exp Med. 2011;208(6):1203-
1214. 
18. Mayle KM, Le AM, Kamei DT. The intracellular trafficking pathway of 
transferrin. Biochim Biophys Acta. 2012;1820(3):264-281. 
19. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The 
transferrin receptor part I: Biology and targeting with cytotoxic 
antibodies for the treatment of cancer. Clin Immunol. 
2006;121(2):144-158. 
20. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage 
function and cellular regulation. Biochim Biophys Acta. 
1996;1275(3):161-203. 
21. Wallace DF, Harris JM, Subramaniam VN. Functional analysis and 
theoretical modeling of ferroportin reveals clustering of mutations 
according to phenotype. Am J Physiol Cell Physiol. 2010;298(1):C75-
84. 
22. Taniguchi R, Kato HE, Font J, et al. Outward- and inward-facing 
structures of a putative bacterial transition-metal transporter with 
homology to ferroportin. Nat Commun. 2015;6:8545. 
23. Taylor M, Qu A, Anderson ER, et al. Hypoxia-inducible factor-2α 
mediates the adaptive increase of intestinal ferroportin during iron 
deficiency in mice. Gastroenterology. 2011;140(7):2044-2055. 
24. Deschemin JC, Vaulont S. Role of hepcidin in the setting of 
hypoferremia during acute inflammation. PLoS One. 
2013;8(4):e61050. 
25. Guida C, Altamura S, Klein FA, et al. A novel inflammatory pathway 
mediating rapid hepcidin-independent hypoferremia. Blood. 
2015;125(14):2265-2275. 
69 
 
26. Lymboussaki A, Pignatti E, Montosi G, Garuti C, Haile DJ, 
Pietrangelo A. The role of the iron responsive element in the control 
of ferroportin1/IREG1/MTP1 gene expression. J Hepatol. 
2003;39(5):710-715. 
27. Qiao B, Sugianto P, Fung E, et al. Hepcidin-induced endocytosis of 
ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 
2012;15(6):918-924. 
28. Gordon S, Martinez FO. Alternative activation of macrophages: 
mechanism and functions. Immunity. 2010;32(5):593-604. 
29. Recalcati S, Locati M, Marini A, et al. Differential regulation of iron 
homeostasis during human macrophage polarized activation. Eur J 
Immunol. 2010;40(3):824-835. 
30. Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and 
metabolism in macrophages: contribution to the polarized 
phenotype. Trends Immunol. 2011;32(6):241-247. 
31. Sica A, Mantovani A. Macrophage plasticity and polarization: in 
vivo veritas. J Clin Invest. 2012;122(3):787-795. 
32. Corna G, Campana L, Pignatti E, et al. Polarization dictates iron 
handling by inflammatory and alternatively activated 
macrophages. Haematologica. 2010;95(11):1814-1822. 
33. Vallelian F, Schaer CA, Kaempfer T, et al. Glucocorticoid treatment 
skews human monocyte differentiation into a hemoglobin-
clearance phenotype with enhanced heme-iron recycling and 
antioxidant capacity. Blood. 2010;116(24):5347-5356. 
34. Prasse A, Pechkovsky DV, Toews GB, et al. A vicious circle of 
alveolar macrophages and fibroblasts perpetuates pulmonary 
fibrosis via CCL18. Am J Respir Crit Care Med. 2006;173(7):781-792. 
35. Mora AL, Torres-González E, Rojas M, et al. Activation of alveolar 
macrophages via the alternative pathway in herpesvirus-induced 
lung fibrosis. Am J Respir Cell Mol Biol. 2006;35(4):466-473. 
36. Kato GJ. Haptoglobin halts hemoglobin's havoc. J Clin Invest. 
2009;119(8):2140-2142. 
70 
 
37. Brancato SK, Albina JE. Wound macrophages as key regulators of 
repair: origin, phenotype, and function. Am J Pathol. 
2011;178(1):19-25. 
38. Wynn TA, Vannella KM. Macrophages in Tissue Repair, 
Regeneration, and Fibrosis. Immunity. 2016;44(3):450-462. 
39. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. 
Macrophage plasticity and polarization in tissue repair and 
remodelling. J Pathol. 2013;229(2):176-185. 
40. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev. 
2001;81(1):449-494. 
41. Castellana D, Paus R, Perez-Moreno M. Macrophages contribute to 
the cyclic activation of adult hair follicle stem cells. PLoS Biol. 
2014;12(12):e1002002. 
42. Mirza R, DiPietro LA, Koh TJ. Selective and specific macrophage 
ablation is detrimental to wound healing in mice. Am J Pathol. 
2009;175(6):2454-2462. 
43. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 
1999;341(10):738-746. 
44. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. 
Dynamic reciprocity in the wound microenvironment. Wound 
Repair Regen. 2011;19(2):134-148. 
45. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen 
FB, Beelen RH. Macrophages in skin injury and repair. 
Immunobiology. 2011;216(7):753-762. 
46. Clark RAF. Wound Repair. In: Clark RAF, ed. The Molecular and 
Cellular Biology of Wound Repair. Boston, MA: Springer US; 1988:3-
50. 
47. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. 
FASEB J. 2004;18(7):816-827. 
48. Lucas T, Waisman A, Ranjan R, et al. Differential roles of 
macrophages in diverse phases of skin repair. J Immunol. 
2010;184(7):3964-3977. 
71 
 
49. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is 
transiently expressed by myofibroblasts during experimental wound 
healing. Lab Invest. 1990;63(1):21-29. 
50. Hinz B. Formation and function of the myofibroblast during tissue 
repair. J Invest Dermatol. 2007;127(3):526-537. 
51. Sindrilaru A, Peters T, Wieschalka S, et al. An unrestrained 
proinflammatory M1 macrophage population induced by iron 
impairs wound healing in humans and mice. J Clin Invest. 
2011;121(3):985-997. 
52. Markolovic S, Wilkins SE, Schofield CJ. Protein Hydroxylation 
Catalyzed by 2-Oxoglutarate-dependent Oxygenases. J Biol 
Chem. 2015;290(34):20712-20722. 
53. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and 
management of non-alcoholic fatty liver disease: practice 
Guideline by the American Association for the Study of Liver 
Diseases, American College of Gastroenterology, and the 
American Gastroenterological Association. Hepatology. 
2012;55(6):2005-2023. 
54. Wynn TA, Barron L. Macrophages: master regulators of 
inflammation and fibrosis. Semin Liver Dis. 2010;30(3):245-257. 
55. Ramachandran P, Iredale JP. Macrophages: central regulators of 
hepatic fibrogenesis and fibrosis resolution. J Hepatol. 
2012;56(6):1417-1419. 
56. Duffield JS, Lupher M, Thannickal VJ, Wynn TA. Host responses in 
tissue repair and fibrosis. Annu Rev Pathol. 2013;8:241-276. 
57. Browning JD, Horton JD. Molecular mediators of hepatic steatosis 
and liver injury. J Clin Invest. 2004;114(2):147-152. 
58. Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T. Morphological 
and functional characterization of non-alcoholic fatty liver disease 
induced by a methionine-choline-deficient diet in C57BL/6 mice. 
Int J Clin Exp Pathol. 2013;6(12):2683-2696. 
59. Sica A, Invernizzi P, Mantovani A. Macrophage plasticity and 
polarization in liver homeostasis and pathology. Hepatology. 
2014;59(5):2034-2042. 
72 
 
60. Barron L, Wynn TA. Fibrosis is regulated by Th2 and Th17 responses 
and by dynamic interactions between fibroblasts and 
macrophages. Am J Physiol Gastrointest Liver Physiol. 
2011;300(5):G723-728. 
61. Pietrangelo A. Iron-induced oxidant stress in alcoholic liver 
fibrogenesis. Alcohol. 2003;30(2):121-129. 
62. Valenti L, Dongiovanni P, Fracanzani AL, Fargion S. HFE mutations in 
nonalcoholic fatty liver disease. Hepatology. 2008;47(5):1794-1795; 
author reply 1795-1796. 
63. Recalcati S, Locati M, Cairo G. Systemic and cellular 
consequences of macrophage control of iron metabolism. Semin 
Immunol. 2012;24(6):393-398. 
64. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol. 
1998;28 Suppl 1:8-13. 
65. Valenti L, Dongiovanni P, Piperno A, et al. Alpha 1-antitrypsin 
mutations in NAFLD: high prevalence and association with altered 
iron metabolism but not with liver damage. Hepatology. 
2006;44(4):857-864. 
66. Valenti L, Fracanzani AL, Bugianesi E, et al. HFE genotype, 
parenchymal iron accumulation, and liver fibrosis in patients with 
nonalcoholic fatty liver disease. Gastroenterology. 2010;138(3):905-
912. 
67. Nakayama Y, Kon S, Kurotaki D, Morimoto J, Matsui Y, Uede T. 
Blockade of interaction of alpha9 integrin with its ligands hinders 
the formation of granulation in cutaneous wound healing. Lab 
Invest. 2010;90(6):881-894. 
68. Weischenfeldt J, Porse B. Bone Marrow-Derived Macrophages 
(BMM): Isolation and Applications. CSH Protoc. 
2008;2008:pdb.prot5080. 
69. Zhang X, Goncalves R, Mosser DM. The isolation and 
characterization of murine macrophages. Curr Protoc Immunol. 
2008;Chapter 14:Unit 14.11. 
70. Delaby C, Pilard N, Gonçalves AS, Beaumont C, Canonne-Hergaux 
F. Presence of the iron exporter ferroportin at the plasma 
73 
 
membrane of macrophages is enhanced by iron loading and 
down-regulated by hepcidin. Blood. 2005;106(12):3979-3984. 
71. Zhang Z, Zhang F, An P, et al. Ferroportin1 deficiency in mouse 
macrophages impairs iron homeostasis and inflammatory 
responses. Blood. 2011;118(7):1912-1922. 
72. Leboeuf RC, Tolson D, Heinecke JW. Dissociation between tissue 
iron concentrations and transferrin saturation among inbred mouse 
strains. J Lab Clin Med. 1995;126(2):128-136. 
73. Morse AC, Beard JL, Jones BC. A genetic developmental model of 
iron deficiency: biological aspects. Proc Soc Exp Biol Med. 
1999;220(3):147-152. 
74. Clothier B, Robinson S, Akhtar RA, et al. Genetic variation of basal 
iron status, ferritin and iron regulatory protein in mice: potential for 
modulation of oxidative stress. Biochem Pharmacol. 2000;59(2):115-
122. 
75. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. 
Identification of erythroferrone as an erythroid regulator of iron 
metabolism. Nat Genet. 2014;46(7):678-684. 
76. Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel 
M, David S. TNF and increased intracellular iron alter macrophage 
polarization to a detrimental M1 phenotype in the injured spinal 
cord. Neuron. 2014;83(5):1098-1116. 
77. Vinchi F, Costa da Silva M, Ingoglia G, et al. Hemopexin therapy 
reverts heme-induced proinflammatory phenotypic switching of 
macrophages in a mouse model of sickle cell disease. Blood. 
2016;127(4):473-486. 
78. Pickens MK, Yan JS, Ng RK, et al. Dietary sucrose is essential to the 
development of liver injury in the methionine-choline-deficient 
model of steatohepatitis. J Lipid Res. 2009;50(10):2072-2082. 
79. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is 
required for very low density lipoprotein secretion from rat 
hepatocytes. J Biol Chem. 1988;263(6):2998-3004. 
80. Caballero F, Fernández A, Matías N, et al. Specific contribution of 
methionine and choline in nutritional nonalcoholic steatohepatitis: 
74 
 
impact on mitochondrial S-adenosyl-L-methionine and glutathione. 
J Biol Chem. 2010;285(24):18528-18536. 
81. Wynn TA, Chawla A, Pollard JW. Macrophage biology in 
development, homeostasis and disease. Nature. 
2013;496(7446):445-455. 
82. Drakesmith H, Nemeth E, Ganz T. Ironing out Ferroportin. Cell 
Metab. 2015;22(5):777-787. 
83. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency 
anemia in transgenic mice expressing liver hepcidin. Proc Natl 
Acad Sci U S A. 2002;99(7):4596-4601. 
84. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required 
to sense iron deficiency. Science. 2008;320(5879):1088-1092. 
85. Folgueras AR, de Lara FM, Pendás AM, et al. Membrane-bound 
serine protease matriptase-2 (Tmprss6) is an essential regulator of 
iron homeostasis. Blood. 2008;112(6):2539-2545. 
86. Kaur S, Raggatt LJ, Batoon L, Hume DA, Levesque JP, Pettit AR. Role 
of bone marrow macrophages in controlling homeostasis and 
repair in bone and bone marrow niches. Semin Cell Dev Biol. 
2017;61:12-21. 
87. Pagani A, Nai A, Corna G, et al. Low hepcidin accounts for the 
proinflammatory status associated with iron deficiency. Blood. 
2011;118(3):736-746. 
88. Roy CN, Custodio AO, de Graaf J, et al. An Hfe-dependent 
pathway mediates hyposideremia in response to 
lipopolysaccharide-induced inflammation in mice. Nat Genet. 
2004;36(5):481-485. 
89. Wang L, Johnson EE, Shi HN, Walker WA, Wessling-Resnick M, 
Cherayil BJ. Attenuated inflammatory responses in 
hemochromatosis reveal a role for iron in the regulation of 
macrophage cytokine translation. J Immunol. 2008;181(4):2723-
2731. 
90. Gan ZS, Wang QQ, Li JH, Wang XL, Wang YZ, Du HH. Iron Reduces 
M1 Macrophage Polarization in RAW264.7 Macrophages 
75 
 
Associated with Inhibition of STAT1. Mediators Inflamm. 
2017;2017:8570818. 
91. Ansell DM, Kloepper JE, Thomason HA, Paus R, Hardman MJ. 
Exploring the "hair growth-wound healing connection": anagen 
phase promotes wound re-epithelialization. J Invest Dermatol. 
2011;131(2):518-528. 
92. Corna G, Caserta I, Monno A, et al. The Repair of Skeletal Muscle 
Requires Iron Recycling through Macrophage Ferroportin. J 
Immunol. 2016;197(5):1914-1925. 
 
